Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678675 · ClinicalTrials.gov registry record · Phase 3
Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial
A Phase 3 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
NCT03678675: Completed Phase 3 study, sponsored by Tufts Medical Center.
NCT03678675 is a Phase 3 study that has completed, run by Tufts Medical Center. The registered enrollment target is 148 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03678675, a Phase 3 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
Study Summary
To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.
Primary Outcome
The amount of MME's will be monitored for each group. MME's will be determined by the amount of opiate mediations administered. The MME value can range from 0 to typically 200 MME's, however there is no upper limit of measureable MME's. The MME's for each patient will be a sum of MME's administered throughout the course of the hospitalization.
Interventions
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 3 |
What the finished NCT03678675 record still lists
NCT03678675 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Ketorolac is the first listed.
NCT03678675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03678675 about?
NCT03678675 is a clinical study titled "Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial". To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.
What is the current status of trial NCT03678675?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2019-05-30. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03678675?
The interventions under investigation include: Ketorolac (DRUG).
Who is sponsoring clinical trial NCT03678675?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03678675's enrollment target sits among peer trials
148 1547th of 2000 higher than 451 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI